Intratympanic dexamethasone as initial therapy for idiopathic sudden sensorineural hearing loss: Clinical evaluation and laboratory investigation

Auris Nasus Larynx, 02/04/2011

Intratympanic dexamethasone at 5 mg/ml did not add effect to systemic steroids in improving hearing outcomes in patients with idiopathic sudden sensorineural hearing loss.

Print Article Summary